Class information for:
Level 1: ZIDOVUDINE//AZT//DIDANOSINE

Basic class information
ID Publications Average number
of references		 Avg. shr. active
ref. in WoS
2546 2142 31.6 76%


Bar chart of Publication_year

Last years might be incomplete

Classes in level above (level 2)


ID, lev.
above		 Publications Label for level above
26 34435 ANTIRETROVIRAL THERAPY//HIV//NEVIRAPINE

Terms with highest relevance score


Rank Term Type of term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 ZIDOVUDINE Author keyword 62 23% 11% 235
2 AZT Author keyword 31 26% 5% 102
3 DIDANOSINE Author keyword 22 26% 3% 71
4 2 3 DIDEOXYINOSINE Author keyword 19 64% 1% 18
5 AZIDOTHYMIDINE Author keyword 17 36% 2% 38
6 APRICITABINE Author keyword 15 88% 0% 7
7 STAVUDINE Author keyword 14 21% 3% 57
8 DIDEOXYINOSINE Author keyword 11 54% 1% 14
9 INTRACELLULAR PHOSPHORYLATION Author keyword 9 83% 0% 5
10 ZALCITABINE Author keyword 8 33% 1% 20

Web of Science journal categories

Author Key Words


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class		 LCSH search Wikipedia search
1 ZIDOVUDINE 62 23% 11% 235 Search ZIDOVUDINE Search ZIDOVUDINE
2 AZT 31 26% 5% 102 Search AZT Search AZT
3 DIDANOSINE 22 26% 3% 71 Search DIDANOSINE Search DIDANOSINE
4 2 3 DIDEOXYINOSINE 19 64% 1% 18 Search 2+3+DIDEOXYINOSINE Search 2+3+DIDEOXYINOSINE
5 AZIDOTHYMIDINE 17 36% 2% 38 Search AZIDOTHYMIDINE Search AZIDOTHYMIDINE
6 APRICITABINE 15 88% 0% 7 Search APRICITABINE Search APRICITABINE
7 STAVUDINE 14 21% 3% 57 Search STAVUDINE Search STAVUDINE
8 DIDEOXYINOSINE 11 54% 1% 14 Search DIDEOXYINOSINE Search DIDEOXYINOSINE
9 INTRACELLULAR PHOSPHORYLATION 9 83% 0% 5 Search INTRACELLULAR+PHOSPHORYLATION Search INTRACELLULAR+PHOSPHORYLATION
10 ZALCITABINE 8 33% 1% 20 Search ZALCITABINE Search ZALCITABINE

Key Words Plus


Rank Web of Science journal category Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 3 AZIDO 3 DEOXYTHYMIDINE 114 31% 14% 306
2 AIDS RELATED COMPLEX 112 24% 19% 417
3 AZIDOTHYMIDINE AZT 87 41% 8% 168
4 TOXIC CATABOLITE 60 100% 1% 20
5 AZIDOTHYMIDINE 59 39% 6% 119
6 2 3 DIDEOXYINOSINE 52 43% 4% 94
7 2 3 DIDEOXYINOSINE DDI 52 50% 3% 74
8 2 DEOXY 3 THIACYTIDINE 40 72% 1% 31
9 AZT 36 21% 7% 156
10 ZIDOVUDINE PHOSPHORYLATION 35 86% 1% 18

Journals

Reviews


Title Publ. year Cit. Active references % act. ref.
to same field
Mechanisms of genotoxicity of nucleoside reverse transcriptase inhibitors 2007 54 76 72%
Metabolism of zidovudine 1995 61 50 90%
The development of antiretroviral therapy and its impact on the HIV-1/AIDS pandemic 2010 128 125 21%
Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs 2004 70 45 53%
Clinical pharmacokinetics of zidovudine - An update 1996 48 47 85%
Nucleoside reverse transcriptase inhibitors and their phosphorylated metabolites in human immunodeficiency virus-infected human matrices 2008 13 139 78%
Comparison of the plasma pharmacokinetics of lamivudine during twice and once daily administration in patients with HIV 2001 31 7 100%
Phosphorylation of nucleoside analog antiretrovirals: A review for clinicians 2001 60 163 59%
Stavudine - A review of its pharmacodynamic and pharmacokinetic properties and clinical potential in HIV infection 1996 76 71 51%
EARLY OR DEFERRED ZIDOVUDINE THERAPY IN HIV-INFECTED PATIENTS WITHOUT AN AIDS-DEFINING ILLNESS - A METAANALYSIS 1995 52 23 70%

Address terms


Rank Address term Relevance score
(tfidf)		 Class's shr.
of term's tot.
occurrences		 Shr. of publ.
in class containing
term		 Num. of
publ. in
class
1 WORLDWIDE CLIN PHARMACOL 5 63% 0.2% 5
2 SECT COMPARAT PSYCHOL 4 32% 0.5% 11
3 CANC TREATMENT CLIN ONCOL PROGRAM 4 75% 0.1% 3
4 CLETS 4 75% 0.1% 3
5 GEORGIA AIDS HIV INFECT 4 75% 0.1% 3
6 CARCINOGEN DNA INTERACT SECT 4 27% 0.6% 13
7 PHARMACOL IMMUNOL UNIT 3 50% 0.2% 5
8 ROOM 5B22 2 67% 0.1% 2
9 CLIN PHARMACOL DATA SCI 2 43% 0.1% 3
10 MED M862 2 43% 0.1% 3

Related classes at same level (level 1)


Rank Relatedness score Related classes
1 0.0000155128 MITOCHONDRIAL TOXICITY//DISTAL SENSORY POLYNEUROPATHY//ANTIRETROVIRAL TOXIC NEUROPATHY
2 0.0000140376 ISONUCLEOSIDE//ISONUCLEOSIDES//AZT ANALOGS
3 0.0000139789 PRONUCLEOTIDES//PROTIDE//PRONUCLEOTIDE
4 0.0000099164 ATAZANAVIR//RITONAVIR//LOPINAVIR
5 0.0000078726 HIV RELATED THROMBOCYTOPENIA//HIV MYELOPATHY//EXPT IMMUNOHEMATOPOIESIS DEV THER EUT
6 0.0000078111 ROYAL FREE HIV MED//CD4 CELL COUNT//X BICHAT MED
7 0.0000074609 MN II CATALYSED//RIBAVIRIN TRIPHOSPHATE//M ANISIDINE
8 0.0000069390 K65R//TRANSMITTED DRUG RESISTANCE//HIV 1 DRUG RESISTANCE
9 0.0000061933 HYDROXYUREA//GENET HUMAN THER Y//TARGET CELL AVAILABILITY
10 0.0000061298 HIV INCUBATION DISTRIBUTION//REPORTING DELAY//NONPROGRESSORS